OPKO Health Inc.
An integrated healthcare company in pharmaceuticals and diagnostic laboratory services.
OPK | TA
Overview
Corporate Details
- ISIN(s):
- US68375N1037
- LEI:
- Country:
- Israel
- Address:
- 4400 Biscayne Blvd., 33137 Miami
- Website:
- https://www.opko.com
- Industry:
- Other human health activities
Description
OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-17 16:03 |
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral G…
|
English | 166.2 KB | ||
| 2025-03-17 16:03 |
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral G…
|
English | 36.3 KB | ||
| 2025-03-16 00:04 |
Proxy Statement for the 2025 Annual Meeting of Stockholders to be held on April…
|
English | 141.8 KB | ||
| 2025-03-16 00:04 |
Proxy Statement for the 2025 Annual Meeting of Stockholders to be held on April…
|
English | 36.2 KB | ||
| 2025-03-16 00:01 |
Notice of the 2025 Annual Meeting of Stockholders to be held on April 23, 2025
|
English | 673.1 KB | ||
| 2025-03-16 00:01 |
Notice of the 2025 Annual Meeting of Stockholders to be held on April 23, 2025
|
English | 36.3 KB | ||
| 2025-03-15 23:54 |
2024 Annual Report on Form 10-K
|
English | 1.2 MB | ||
| 2025-03-15 23:54 |
2024 Annual Report on Form 10-K
|
English | 36.2 KB | ||
| 2025-03-11 21:21 |
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovat…
|
English | 130.6 KB | ||
| 2025-03-11 21:21 |
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovat…
|
English | 36.4 KB | ||
| 2025-03-11 14:24 |
FORM 8-K- BioReference and Buyer entered into an Asset Purchase Agreement
|
English | 481.4 KB | ||
| 2025-03-11 14:24 |
FORM 8-K- BioReference and Buyer entered into an Asset Purchase Agreement
|
English | 36.4 KB | ||
| 2025-03-05 09:38 |
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
|
English | 51.1 KB | ||
| 2025-03-05 09:38 |
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
|
English | 36.2 KB | ||
| 2025-03-04 10:04 |
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Phillip Frost
|
English | 54.9 KB |
Automate Your Workflow. Get a real-time feed of all OPKO Health Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OPKO Health Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OPKO Health Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
